Author | Mohammed Rahman, MD | OncLive

Author | Mohammed Rahman, MD

Articles

Dr. Rahman on Pertuzumab and Neratinib in HER2+ Breast Cancer

November 07, 2018

Video

Mohammed J. Rahman, MD, oncologist, University of Pittsburgh Medical Center, discusses the roles of pertuzumab and neratinib in patients with HER2-positive breast cancer.

x